sacituzumab
gilead sciences
['tropics02', 'sacituzumab', 'sacitu, govi']
#esmo22 tropics02 os - hope rugo
sacituzumab govitecan in hr+/her2- vs treatment of physicians choice
prior pfs data positive 61% vs 47% at 12 months positive at 2nd interim analysis orr 21% vs 14% global qol and fatigue but not pain outcomes better on pros 
Medical oncologist from Perth - Australia. Interested in thoracic oncology, breast cancer, GUs, clinical trials, fast cars (Formula 1) and @werderbremen_en